home / stock / abbv / abbv articles

ABBV Articles, AbbVie Inc. - From 04/10/24

Stock Information
Company Name: AbbVie Inc.
Stock Symbol: ABBV
Market: NYSE
Website: abbvieinvestor.com
Menu
ABBV ABBV Quote ABBV Short ABBV News ABBV Articles ABBV Message Board
Get ABBV Alerts

News, Short Squeeze, Breakout and More Instantly...
Blindness-Focused LENZ Therapeutics' Investigational Eye Drop Ready To Revolutionize Presbyopia Landscape, Analyst Says | Benzinga

Last week, LENZ Therapeutics Inc (NASDAQ:LENZ) released topline results from its Phase 3 CLARITY study of two investigational formulation...
FibroGen Unveils Early Data From Prostate Cancer Candidate, Analyst Advocates Further Exploration In The Landscape | Benzinga

FibroGen Inc (NASDAQ:FGEN) announced topline data from the Fortis Therapeutics-sponsored Phase 1 study of FG-3246 (also known as FOR46), a pot...

Assessing AbbVie's Performance Against Competitors In Biotechnology Industry | Benzinga

In the fast-paced and highly competitive business world of today, conducting thorough company analysis is essential for investors and industry obse...

Nasdaq Turns Higher; Akanda Shares Plunge | Benzinga

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Monday. The Dow traded down 0.37% to 39,331.42 whil...
Why Landos Biopharma Shares Are Trading Higher By Over 170%? Here Are Other Stocks Moving In Monday's Mid-Day Session | Benzinga

Shares of Landos Biopharma, Inc. (NASDAQ: LABP) rose sharply during Monday’s session following acquisition news. AbbVie Inc. (NYSE: ABBV) an...

Crude Oil Moves Higher; US New Home Sales Fall In February | Benzinga

U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,3...

Why Is Ulcerative Colitis-Focused Landos Biopharma Stock Trading Higher On Monday? | Benzinga

Monday, AbbVie Inc (NYSE:ABBV) agreed to acquire Landos Biopharma Inc (NASDAQ:LABP) for $20.42 per share, or approximately $137...
US Stocks Down; Chicago Fed National Activity Index Rises In February | Benzinga

U.S. stocks traded lower this morning, with the Dow Jones index falling more than 50 points on Monday. Following the market opening Monday, the Dow...

AbbVie to Acquire Landos Biopharma, Further Strengthening its Portfolio in Inflammatory and Autoimmune Diseases | Benzinga

NORTH CHICAGO, Ill. and NEW YORK, March 25, 2024 (GLOBE NEWSWIRE) -- AbbVie Inc. (NYSE:ABBV) ("AbbVie") and Landos Biopharma, Inc. (NASDAQ:LABP)...

AbbVie Recent Insider Activity | Benzinga

Making a noteworthy insider sell on March 20, Jeffrey R. Stewart, EVP at AbbVie (NYSE:ABBV), is reported in the latest SEC filing. What Happened: A...
Previous 10 Next 10